BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31950467)

  • 21. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical Fibroxanthoma Demonstrating HMB45+ Staining.
    Sahni VN; Sahni DR; Cassarino DS
    Am J Dermatopathol; 2021 Dec; 43(12):e218-e221. PubMed ID: 34132658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Atypical fibroxanthoma of the scalp: overview and recent developments].
    Hilgers M; Wahl RU; Megahed M
    Hautarzt; 2014 Dec; 65(12):1008-10. PubMed ID: 25392128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemistry: a useful adjunct in the evaluation of malignant cutaneous spindle cell tumors.
    Walker AN; Morton BD
    South Med J; 1988 Dec; 81(12):1505-8. PubMed ID: 3201297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the lymphatic vessel architecture of atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Zschoche C; Hamsch C; Kutzner H; Mentzel T; Werchau S; Enk A; Hartschuh W; Hadaschik E; Toberer F
    J Am Acad Dermatol; 2014 Oct; 71(4):842-5. PubMed ID: 25219715
    [No Abstract]   [Full Text] [Related]  

  • 26. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas".
    Silvis NG; Swanson PE; Manivel JC; Kaye VN; Wick MR
    Am J Dermatopathol; 1988 Feb; 10(1):9-19. PubMed ID: 3177827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous metaplastic carcinoma: report of a case involving angiosarcoma.
    Kantrow SM; Boyd AS
    Am J Dermatopathol; 2007 Jun; 29(3):270-3. PubMed ID: 17519625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
    Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
    Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
    Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
    J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
    Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
    Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
    Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
    Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma.
    Nappi O; Wick MR; Pettinato G; Ghiselli RW; Swanson PE
    Am J Surg Pathol; 1992 May; 16(5):429-38. PubMed ID: 1599022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report.
    Smith-Zagone MJ; Prieto VG; Hayes RA; Timperman WW; Diwan AH
    J Cutan Pathol; 2004 Mar; 31(3):284-6. PubMed ID: 14984584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleomorphic Dermal Sarcoma.
    Saleh JS; Whittington CP; Bresler SC; Patel RM
    Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
    Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
    Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical fibroxanthoma: a selective review.
    Gru AA; Santa Cruz DJ
    Semin Diagn Pathol; 2013 Feb; 30(1):4-12. PubMed ID: 23327726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous undifferentiated pleomorphic sarcoma is a pleomorphic dermal sarcoma.
    Cohen PR
    Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
    Folpe AL; Cooper K
    Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.